- Report
- October 2024
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 196 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2023
- 202 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2024
- 112 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- October 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- June 2023
- 132 Pages
Global
From €903EUR$950USD£759GBP
The Next Generation RNA Sequencing (NGS) market is a rapidly growing segment of the genomics industry. NGS is a powerful tool for studying gene expression, which is the process by which genetic information is used to produce proteins and other molecules. NGS enables researchers to analyze the expression of thousands of genes simultaneously, providing a comprehensive view of gene expression in a single experiment. This technology has been used to study a wide range of biological processes, including cancer, neurological disorders, and infectious diseases.
NGS has also been used to identify novel biomarkers and therapeutic targets, as well as to develop personalized medicine. In addition, NGS has enabled researchers to study the evolution of genes and to identify genetic variants associated with disease.
Companies in the Next Generation RNA Sequencing market include Illumina, Thermo Fisher Scientific, BGI, Oxford Nanopore Technologies, Pacific Biosciences, and 10X Genomics. Show Less Read more